Abstract
Rho GTPases, which control processes such as cell proliferation and cytoskeleton remodeling, are often hyperexpressed in tumors. Several members, such as RhoA/B/C, must be isoprenylated to interact with their effectors. Statins, by inhibiting the synthesis of prenyl groups, may affect RhoA/B/C activity and represent a promising tool in anticancer therapy.
Keywords: Cancer, chemotherapy, isoprenylation, rho GTPases, statins.
About this chapter
Cite this chapter as:
Ivana Campia, Sophie Doublier, Elisabetta Aldieri, Amalia Bosia, Dario Ghigo, Chiara Riganti ;Rho-GTPases and Statins: A Potential Target and a Potential Therapeutic Tool Against Tumors?, Recent Advances in Medicinal Chemistry (2014) 1: 209. https://doi.org/10.2174/9781608057962114010010
DOI https://doi.org/10.2174/9781608057962114010010 |
Publisher Name Bentham Science Publisher |